Deprivation-based risk scores: The re-emergence of postcode prescribing in the UK?

Journal of Cardiovascular Medicine

Volumn 10, Issue 2, 2009, Pages 157-160

  Payne, Rupert A ^a   Maxwell, Simon R J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

ASSIGN; Cardiovascular risk; Deprivation; Postcode prescribing

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOVASCULAR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BORDERLINE HYPERTENSION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; POPULATION; PRESCRIPTION; PREVENTIVE MEDICINE; PRIMARY PREVENTION; RESIDENTIAL CARE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SOCIAL STATUS; SOCIOECONOMICS; UNITED KINGDOM; CLINICAL PRACTICE; DEMOGRAPHY; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; MIDDLE AGED; PATIENT SELECTION; POVERTY; PRACTICE GUIDELINE; SOCIAL CLASS; SOCIAL ISOLATION; STATISTICS;

ADULT; AGED; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES ACCESSIBILITY; HEALTH SURVEYS; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; POVERTY; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; PSYCHOSOCIAL DEPRIVATION; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; SCOTLAND; SOCIAL CLASS;

EID: 65549168363     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32831fb0c2     Document Type: Article

References (24)

1. US Department of Health and Human Services. A public health action plan to prevent heart disease and stroke. Washington, DC: US Department of Health and Human Services; 2003.
2. Department of Health. National Service Framework for coronary heart disease. London: Department of Health; 2000.
3. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121:293-298.
4. National Institute for Health and Clinical Excellence (NICE). Management of hypertension in adults in primary care. London: Royal College of Physicians; 2006.
5. Scottish Intercollegiate Guidelines Network (SIGN). Risk estimation and the prevention of cardiovascular disease: a national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN); 2007.
6. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
7. Department of Health. Prescription cost analysis. London: Department of Health; 2005.
8. Marmot MG, Rose G, Shipley M, Hamilton PJ. Employment grade and coronary heart disease in British civil servants. J Epidemiol Commun Health 1978; 32:244-249. (Pubitemid 9067829)
9. Brindle PM, McConnachie A, Upton MN, Hart CL, Davey SG, Watt GC. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract 2005; 55:838-845. (Pubitemid 41683997)
10. Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, Ruidavets JB, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003; 24:1903-1911. (Pubitemid 37322699)
11. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93:172-176. (Pubitemid 46180289)
12. Scottish Executive. Scottish Index of Multiple Deprivation. Edinburgh: Scottish Executive; 2004.
13. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007; 335:136. (Pubitemid 47172233)
14. Scottish Executive. The Scottish Health Survey. Cardiovascular disease and associated factors. vol.1. Edinburgh: Scottish Executive; 2005.
15. Stocks NP, Ryan P, McElroy H, Allan J. Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study. Med J Aust 2004; 180:229-231. (Pubitemid 38312985)
16. Waitzman NJ, Smith KR. Phantom of the area: poverty-area residence and mortality in the United States. Am J Pub Health 1998; 88:973-976.
17. de Godoy MF, de Lucena JM, Miquelin AR, Paiva FF, Oliveira DL, Augustin JL Jr, et al. Cardiovascular mortality and its relation to socioeconomic levels among inhabitants of São José do Rio Preto, São Paulo state, Brazil. Arq Bras Cardiol 2007; 88:200-206.
18. Stjä rne MK, Ponce de Leon A, Hallqvist J. Contextual effects of social fragmentation and material deprivation on risk of myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP). Int J Epidem 2004; 33:732-741.
19. Parsons A, Johnstone A. Postcode prescribing and the Human Rights Act 1998. J R Soc Med 2001; 94:159-160.
20. Bailey N, Flint J, Goodlad R, Shucksmith M, Fitzpatrick S, Pryce G. Measuring deprivation in Scotland: developing a long-term strategy. Edinburgh: Scottish Executive Central Statistics Unit; 2003.
21. Rose D, O'Reilly K. The ESRC Review of Government Social Classifications: final report. London: The Stationery Office; 1998.
22. Prandy K. The revised Cambridge scale of occupations. Sociology 1990; 24:629-655.
23. Sass C, Dupré C, Dauphinot V, Labbe E, Guéguen R, Gerbaud L, et al. The EPICES score: an individual index of material and social deprivation related to health status. Part 2: Evaluation in a population of 197389 subjects. http://www.cetaf.asso.fr/protocoles/precarite/protocoles- epices.htm#publis. [Accessed September 2008].
24. Bihan H, Laurent S, Sass C, Nguyen G, Huot C, Moulin JJ, et al. Association among individual deprivation, glycemic control, and diabetes complications: the EPICES score. Diabetes Care 2005; 28:2680-2685. (Pubitemid 43951159)